docetaxel

Can Bone Pain Predict Survival in Men with Metastatic Hormone-Refractory Prostate Cancer Treated with Docetaxel? What are the Implications?

A small study of 145 men with asymptomatic metastatic hormone-refractory prostate cancer (HRPC) was conducted to determine the benefit of starting early chemotherapy with docetaxel. Collected data were analyzed from these subjects who were treated with chemotherapy between February 2000 and June 2002 in one French center. The men were categorized into three groups according [...]

By Malecare|2009-03-16T08:11:28-04:00March 16th, 2009|Advanced Prostate Cancer, Drugs & Treatments, Metastases, Research, Uncategorized, Understanding APC|0 Comments

Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer Is Viable

There have been very few studies on the patterns of care and outcome of elderly (over 75 years) survivors with androgen independent prostate cancer (AIPC) who have been treated with docetaxel (Taxotere). The records of 175 French men with AIPC, over the age of 75 years, were retrospectively examined. All of the men were treated [...]

By Malecare|2017-10-19T10:57:01-04:00September 19th, 2008|Advanced Prostate Cancer, Chemo Therapy, Drugs & Treatments, Uncategorized|1 Comment

Previous 56